Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Cannon

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Controlled Clinical Trials|December 31, 1997
Clinical perspectives on the use of composite endpointsC P Cannon
Clinical Cardiology|September 24, 1999
Breaking the therapeutic barriers: new strategies for acute coronary syndromesC P Cannon
Clinical Cardiology|September 24, 1999
Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarctionC P Cannon
Contemporary Internal Medicine|April 8, 1995
Improved management of unstable angina and non-Q-wave MIC P Cannon
Contemporary Internal Medicine|July 7, 1994
Advances in the treatment of acute MIC P Cannon
Journal of Thrombosis and Thrombolysis|March 23, 2000
Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCIC P Cannon
The American Journal of Cardiology|May 4, 2000
Thrombolysis medication errors: benefits of bolus thrombolytic agentsC P Cannon
Current Opinion in Cardiology|March 26, 1999
Time to treatment of acute myocardial infarction revisitedC P Cannon
Cardiology Clinics|August 1, 1995
Thrombin inhibitors in acute myocardial infarctionC P Cannon
Current Opinion in Cardiology|November 21, 1998
Advances in the medical management of acute coronary syndromesC P Cannon
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Controlled Clinical Trials|December 31, 1997
Clinical perspectives on the use of composite endpointsC P Cannon
Clinical Cardiology|September 24, 1999
Breaking the therapeutic barriers: new strategies for acute coronary syndromesC P Cannon
Clinical Cardiology|September 24, 1999
Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarctionC P Cannon
Contemporary Internal Medicine|April 8, 1995
Improved management of unstable angina and non-Q-wave MIC P Cannon
Contemporary Internal Medicine|July 7, 1994
Advances in the treatment of acute MIC P Cannon
Journal of Thrombosis and Thrombolysis|March 23, 2000
Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCIC P Cannon
The American Journal of Cardiology|May 4, 2000
Thrombolysis medication errors: benefits of bolus thrombolytic agentsC P Cannon
Current Opinion in Cardiology|March 26, 1999
Time to treatment of acute myocardial infarction revisitedC P Cannon
Cardiology Clinics|August 1, 1995
Thrombin inhibitors in acute myocardial infarctionC P Cannon
Current Opinion in Cardiology|November 21, 1998
Advances in the medical management of acute coronary syndromesC P Cannon
Pageof 15